Teicoplanin

CAS No. 61036-62-2

Teicoplanin( Antibiotic 8327A | Antibiotic MDL 507 | MDL 507 )

Catalog No. M15294 CAS No. 61036-62-2

Teicoplanin is a semisynthetic glycopeptide antibiotic used in the prophylaxis and treatment of serious infections caused by Gram-positive bacteria.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 40 In Stock
50MG 53 In Stock
100MG 80 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Teicoplanin
  • Note
    Research use only, not for human use.
  • Brief Description
    Teicoplanin is a semisynthetic glycopeptide antibiotic used in the prophylaxis and treatment of serious infections caused by Gram-positive bacteria.
  • Description
    Teicoplanin is a semisynthetic glycopeptide antibiotic used in the prophylaxis and treatment of serious infections caused by Gram-positive bacteria, including Methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.
  • In Vitro
    ——
  • In Vivo
    Animal Model:20-30 g, Male CD1 mice (2?*?106 cfu/mL MRSA (43?300) 50 μL; murine thigh infection model)Dosage:10, 30 mg/kg Administration:I.v.; once every 12?h Result:Showed a dose-dependent decline in the total bacterial density with the total bactericidal effect was achieved with dosages of ≥10?mg/kg/day and suppression of resistance with dosages ≥30?mg/kg/day.
  • Synonyms
    Antibiotic 8327A | Antibiotic MDL 507 | MDL 507
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    61036-62-2
  • Formula Weight
    1709.39
  • Molecular Formula
    C77H77N5O31CI2R
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 100 mg/mL (58.5 mM)
  • SMILES
    CCCCCCCCC/C(O)=N/[C@]([C@@](OC1=C2C=C([C@](/N=C(O)\[C@](/N=C(O)/[C@@](/N=C(O)\[C@@](N)([H])C3=CC4=C(O)C=C3)([H])CC5=CC(Cl)=C(O2)C=C5)([H])C6=CC(O)=CC(O4)=C6)([H])/C(O)=N/[C@](/C(O)=N/7)([H])C8=CC(C9=C([C@@]%10([H])C(O)=O)C=C(O)C=C9OC%11([H])[C@](O)([H])[C@](O)([H])[C@@](O)([H])[C@@](O%11)([H])CO)=C(O)C=C8)C=C1OC%12=C(Cl)C=C([C@](O[C@@]%13([H])[C@@](/N=C(O)/C)([H])[C@](O)([H])[C@@](O)([H])[C@@](O%13)([H])CO)([H])[C@@]7([H])/C(O)=N/%10)C=C%12)([H])O%14)([H])[C@](O)([H])[C@@](O)([H])[C@@]%14([H])CO
  • Chemical Name
    34-O-[2-(acetylamino)-2-deoxy-.beta.-D-glucopyranosyl]-22,31-dichloro-7-demethyl-64-O-demethyl-19-deoxy-56-O-[2-deoxy-2-[(8-methyl-1-oxononyl)amino]-.beta.-D-glucopyranosyl]-42-O-.alpha.-D-mannopyranosyl-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bereczki I, et al. Bioorg Med Chem Lett. 2014 Aug 1;24(15):3251-4.
molnova catalog
related products
  • Hydroumbellic acid

    Hydroumbellic acid is a predicted metabolite generated by BioTransformer1 that is produced by the metabolism of 3-(2, 4-dihydroxyphenyl)prop-2-enoic acid.

  • Diazo Biotin-PEG3-al...

    Diazo Biotin-PEG3-alkyne is a polyethylene glycol (PEG)-based linker designed specifically for the synthesis of proteolysis-targeting chimeras (PROTACs) .

  • L-Asparaginase

    L-Asparaginase (L-?ASNase), a hydrolase that catalyzes the conversion of L-asparagine, used in acute lymphoblastic leukemia treatment.Asparaginase is an enzyme that is used as a medication. As a medication, L-asparaginase is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin.